estim
frequenc
molecular
epidemiolog
clinic
associ
infect
newli
describ
speci
c
variant
human
rhinovirus
hrv
diagnost
respiratori
sampl
refer
diagnost
test
edinburgh
screen
use
regionbas
select
polymeras
chain
reaction
pcr
hrvc
along
parallel
pcr
test
respiratori
virus
hrvc
third
frequent
detect
behind
respiratori
syncyti
viru
rsv
adenoviru
infect
episod
detect
among
subject
month
infect
predominantli
target
young
median
age
month
infect
year
occur
throughout
year
peak
incid
earli
winter
month
hrvc
detect
significantli
frequent
among
subject
lower
lrt
upper
respiratori
tract
urt
diseas
control
without
respiratori
symptom
hrvc
monoinfect
second
frequent
detect
viru
behind
rsv
diseas
present
case
respect
hrv
variant
classifi
sequenc
genotyp
defin
type
increas
current
total
worldwid
sequenc
comparison
region
major
group
speci
n
describ
hrvca
remaind
form
phylogenet
distinct
group
hrvcc
multipl
bidirect
recombin
event
hrvca
hrvcc
variant
hrv
speci
repres
parsimoni
explan
interspers
phylogeni
relationship
region
differ
age
distribut
season
diseas
associ
identifi
hrvca
hrvcc
variant
hrvcinfect
subject
show
markedli
reduc
detect
frequenc
rsv
respiratori
virus
provid
evid
major
interf
effect
hrvc
suscept
respiratori
viru
infect
hrvc
diseas
associ
preval
evid
interf
effect
respiratori
virus
mandat
incorpor
rhinovirus
futur
diagnost
virolog
screen
human
rhinovirus
hrv
member
recent
expand
enteroviru
genu
within
famili
picornavirida
genom
organis
structur
typic
picornavirus
possess
base
singl
strand
rna
genom
nonenvelop
virion
approxim
nm
diamet
human
rhinovirus
origin
classifi
two
speci
b
like
distinct
evolutionari
separ
origin
within
enteroviru
genu
howev
share
primari
tropism
respiratori
tract
speci
b
speci
variant
use
intracellular
adhes
receptor
entri
acidlabil
hrv
colonis
gut
commonli
transmit
respiratorysalivari
rout
persontoperson
contact
airborn
transmiss
temper
countri
infect
occur
primarili
two
peak
first
april
may
second
septemb
octob
recent
wider
use
molecular
detect
method
viral
diagnost
screen
reveal
quit
unexpect
exist
speci
human
rhinovirus
speci
c
rhinovirus
hrvc
shown
highli
preval
initi
studi
demonstr
frequent
detect
speci
associ
bronchiol
lower
respiratori
tract
diseas
asthma
exacerb
otiti
media
hrv
show
remark
genet
antigen
heterogen
serotyp
classifi
crossneutralis
assay
speci
b
virus
respect
although
speci
c
variant
yet
isol
cultur
vitro
therefor
formal
assign
separ
serotyp
exist
sequenc
data
reveal
perhap
even
greater
genet
heterogen
found
within
hrva
hrvb
larg
number
distinct
genet
lineag
identifi
sequenc
comparison
gene
region
may
thu
correspond
differ
serotyp
hrvc
furthermor
sequenc
diverg
extern
region
capsid
actual
greater
differ
hrva
b
serotyp
impli
exist
major
antigen
differ
influenc
immunolog
crossprotect
newli
discov
speci
addit
aspect
hrvc
genet
divers
caus
confus
previou
attempt
hrv
speci
identif
type
occurr
recombin
hrva
hrva
untransl
region
speci
b
rhinovirus
phylogenet
distinct
sequenc
region
major
hrvc
variant
resembl
speci
remaind
form
phylogenet
separ
group
distinct
hrva
hrvb
enteroviru
speci
initi
data
howev
show
differ
clinic
present
hrvc
variant
c
sequenc
describ
hrvca
hrvcc
respect
nomenclatur
follow
current
studi
current
studi
develop
select
gene
pcrbase
amplif
method
specif
detect
hrvc
respiratori
specimen
enabl
us
screen
clinic
characteris
infect
occur
whole
calendar
year
month
studi
group
subject
parallel
screen
human
respiratori
virus
period
allow
us
directli
compar
epidemiolog
associ
specif
diseas
present
intent
studi
investig
incid
genet
variabl
clinic
present
hrvc
collect
whole
calendar
year
nonselect
amplif
hrv
hev
speci
use
previous
develop
pcr
method
would
identifi
extrem
larg
number
nonhrvc
posit
sampl
would
preclud
effect
screen
use
pool
overcom
modifi
region
pcr
previous
use
genet
characteris
sero
type
identif
hrv
enabl
select
amplif
hrvc
inner
antisens
primer
reposit
variabl
posit
gene
speci
b
c
sequenc
enabl
select
hybridis
strand
extens
hrvc
sequenc
sensit
specif
select
pcr
evalu
use
sampl
previous
identifi
hrva
b
c
variant
previou
studi
speci
c
sampl
posit
along
speci
speci
b
sampl
assay
sensit
specif
sinc
posit
sampl
sequenc
variabl
region
minor
degre
nonspecif
would
influenc
identif
hrvc
posit
sampl
studi
exclud
sampl
septemb
februari
alreadi
test
control
assay
valid
assay
use
screen
remain
sampl
septemb
septemb
compris
total
sampl
collect
studi
subject
initi
combin
pool
posit
pool
split
retest
previous
describ
total
sampl
posit
initi
screen
nucleotid
sequenc
amplifi
gene
region
sampl
identifi
belong
speci
c
remaind
compris
hrva
n
hrvb
n
human
enteroviru
speci
b
n
select
primer
therefor
moder
effect
select
amplif
speci
c
variant
overal
specif
screen
popul
hrv
speci
predomin
screen
data
select
primer
combin
result
previou
screen
sampl
collect
septemb
februari
yield
combin
sampl
studi
group
hrvc
posit
sampl
origin
differ
individu
result
refer
sequenc
amplifi
sequenc
region
compar
obtain
previou
studi
sequenc
download
genbank
august
amongst
latter
previous
deposit
sequenc
total
put
hrvc
geno
type
could
assign
use
previous
describ
criteria
gene
phylogeni
pairwis
distanc
threshold
compar
method
studi
sampl
compris
type
fig
distinct
previous
deposit
hrvc
sequenc
produc
combin
total
frequenc
reinfect
persist
hrvc
among
subject
contribut
one
posit
sampl
studi
period
estim
sequenc
comparison
region
subject
repeatedli
posit
hrvc
calendar
month
gene
sequenc
similar
ident
posit
sampl
separ
one
month
longer
invari
infect
differ
hrvc
type
close
concord
sampl
time
evid
reinfect
allow
us
identifi
separ
infect
episod
subject
except
correl
longterm
hospitalis
patient
acut
myeloid
leukaemia
regularli
screen
month
studi
period
total
posit
sampl
collect
obtain
close
sequenc
similar
hrvc
variant
period
mark
fig
subject
id
indic
longterm
persist
hrvc
infect
context
like
sever
immunosuppress
group
hrvc
posit
sampl
studi
determin
amplif
sequenc
region
analysi
assist
inclus
publish
hrvc
gene
sequenc
group
determin
includ
avail
complet
genom
sequenc
hrvc
data
shown
major
hrvc
variant
characteris
current
studi
separ
infect
episod
contain
speci
alik
sequenc
term
hrvca
clade
hrvc
type
differ
group
hrvca
hrvcc
interspers
within
gene
tree
fig
impli
exist
multipl
recombin
event
past
diversif
hrvc
gener
variant
geno
type
assign
region
contain
group
howev
two
except
hrvca
sampl
cluster
close
hrvcc
variant
fig
split
one
genotyp
hrvca
publish
sequenc
china
hrvcc
sampl
amplifi
differ
studi
subject
edinburgh
observ
impli
ongo
bidirect
frequent
recent
recombin
event
rhinovirus
differ
group
epidemiolog
clinic
inform
studi
sampl
subject
retain
anonymis
process
use
compar
season
age
distribut
hrvc
infect
common
respiratori
viru
infect
fig
contrast
rsv
influenza
viru
show
pronounc
increas
incid
winter
month
hrvc
infect
occur
year
round
similar
incid
calendar
month
investig
current
studi
fig
compar
adenoviru
contrast
hrvc
resembl
rsv
close
target
young
children
infant
peak
incid
virus
occur
month
age
rang
younger
age
distribut
adenoviru
infect
distinct
wide
age
rang
influenza
viru
fig
hrvc
infect
observ
children
younger
year
age
systemat
differ
evid
hrvca
hrvcc
season
distribut
age
rang
infect
detect
frequenc
hrvc
respiratori
virus
among
subject
present
lrti
urti
without
respiratori
symptom
compar
fig
subject
compar
present
acut
exclud
underli
immunosuppress
sever
underli
diseas
see
method
criteria
assign
diseas
categori
one
respiratori
viru
detect
subject
lrti
urti
relev
respiratori
symptom
diagnos
divid
group
hrvc
viru
detect
lrti
case
urti
higher
nonrespiratori
diseas
control
second
rsv
detect
frequenc
respect
hrvc
twice
frequent
detect
subject
respiratori
diseas
without
relev
symptom
p
chisquar
test
hrvc
detect
children
paediatr
intens
care
unit
patient
mostli
pneumonia
without
caus
identifi
neonat
intens
care
patient
signific
differ
diseas
categori
proport
hrvca
hrvcc
variant
evid
signific
interact
respiratori
virus
obtain
comparison
detect
frequenc
monoand
doublyinfect
individu
fig
hrvc
nearli
three
time
commonli
detect
coinfect
adenoviru
monoinfect
subject
exampl
neg
interact
addit
observ
strikingli
hrvc
highli
signific
effect
detect
frequenc
rsv
respiratori
virus
rsv
monoinfect
found
sampl
virtual
absent
among
hrvc
infect
subject
respiratori
virus
exclud
adv
reduct
infect
frequenc
observ
hrvc
coinfect
subject
reduct
greater
effect
rsv
coinfect
detect
frequenc
contrast
rsv
group
respiratori
virus
significantli
influenc
likelihood
hrvc
detect
studi
subject
show
hrvc
monoinfect
frequenc
compar
coinfect
rsv
respiratori
virus
respect
togeth
observ
indic
hrvc
inhibit
rsv
respiratori
infect
rather
convers
studi
repres
one
first
larg
scale
investig
epidemiolog
clinic
impact
focuss
newli
discov
speci
c
rhinovirus
provid
evid
figur
phylogeni
gene
sequenc
amplifi
studi
subject
comparison
correspond
full
length
sequenc
hrvc
sampl
group
previous
assign
symbol
identifi
hrvcc
ie
speci
clike
sequenc
hrvca
speci
alik
describ
key
neighbourjoin
tree
construct
use
maximum
composit
likelihood
distanc
estim
sequenc
amplifi
region
posit
number
accord
refer
sequenc
data
bootstrap
resampl
time
assess
robust
branch
valu
greater
shown
sequenc
show
incompat
phylogenet
group
suggest
recombin
arrow
signific
role
childhood
respiratori
diseas
hrvc
third
preval
viru
studi
popul
infect
episod
detect
among
subject
month
period
rsv
adenoviru
detect
frequent
genet
comparison
region
hrvc
infect
found
almost
invari
acuteresolv
evid
persist
among
multipli
sampl
individu
singl
except
immunocompromis
child
aml
reinfect
occur
invari
anoth
hrvc
type
consist
hypothesi
speci
c
type
assign
basi
gene
sequenc
diverg
might
nevertheless
antigen
distinct
capabl
infect
expos
previous
heterolog
type
find
consist
previou
observ
day
period
viru
shed
hrv
immunocompet
individu
given
high
incid
hrv
infect
ongo
exposur
circul
sero
type
molecular
characteris
requir
clearli
document
hrv
persist
contribut
high
incid
hrvc
genet
like
antigen
divers
evid
among
variant
detect
current
studi
analysi
publish
sequenc
region
total
type
could
provision
assign
although
nucleotid
sequenc
diverg
region
use
indirectli
infer
antigen
variabl
part
genom
pairwis
distanc
threshold
region
match
diverg
effect
categoris
hrv
speci
b
constitu
serotyp
sequenc
comparison
region
thu
remain
use
provision
assign
tool
sequenc
whole
capsidencod
region
becom
avail
sequenc
comparison
sampl
identifi
posit
gene
screen
possibl
classifi
posit
sampl
two
group
sequenc
similar
speci
rhinovirus
describ
hrvca
cluster
separ
speci
b
human
enterovirus
describ
hrvcc
complet
genom
sequenc
fall
hrvcc
group
eight
other
avail
includ
speci
c
prototyp
strain
qpm
possess
sequenc
group
within
hrv
speci
sequenc
hrvca
apart
complet
genom
sequenc
publish
sequenc
data
gene
region
avail
chines
speci
c
strain
classifi
hrvca
hrvcc
variant
studi
south
korea
itali
separ
speci
c
variant
hrvca
hrvcc
group
although
gene
sequenc
deposit
onto
genbankembl
could
includ
analysi
fig
multipl
interspers
phylogenet
posit
sequenc
hrvca
hrvcc
variant
consist
multipl
interspeci
recombin
event
evolutionari
histori
human
rhinovirus
know
like
reconstruct
actual
evolutionari
step
creat
complex
phylogeni
relationship
genom
region
natur
ancestor
current
circul
speci
c
rhinovirus
nevertheless
parsimoni
explan
scatter
hrvcc
hrvca
variant
tree
seri
recombin
event
earli
diversif
ancestor
hrvc
current
larg
number
type
exist
one
recombin
event
speci
c
descend
origin
recombin
recent
evolutionari
origin
rel
rhinovirus
circul
time
would
expect
remain
close
relat
monophylet
gene
region
elsewher
genom
clearli
case
gene
region
fig
publish
hrvca
variant
complet
genom
sequenc
china
fall
least
two
separ
group
latter
region
occurr
multipl
recombin
event
consist
recent
observ
differ
recombin
breakpoint
differ
hrvca
hrvcc
variant
observ
variant
within
speci
c
type
usual
group
fig
suggest
recombin
occur
earli
diversif
hrvc
howev
variant
current
studi
differ
group
member
type
hrvca
strain
cluster
hrvcc
variant
although
anomal
result
verifi
independ
reextract
reamplif
sampl
member
clade
group
remain
formal
possibl
studi
subject
coinfect
two
differ
rhinoviru
variant
pcr
assay
use
gene
primer
may
amplifi
differ
speci
alik
sequenc
possess
speci
c
viru
sequenc
gene
notwithstand
anoth
recent
intratyp
recombin
event
could
infer
cluster
close
relat
hrvcc
variant
current
studi
sever
publish
hrvca
sequenc
china
speci
c
type
fig
given
evid
frequent
like
ongo
recombin
remain
difficult
explain
known
speci
rhinoviru
recombin
speci
c
sequenc
perhap
ongo
recombin
event
restrict
hrvca
hrvcc
mani
respect
phylogeni
relationship
observ
rhinovirus
code
region
resembl
human
enterovirus
santti
et
al
show
sequenc
heva
b
similarli
interspers
region
sequenc
speci
c
impli
similar
process
frequent
interspeci
recombin
whether
interspeci
recombin
rhinoviru
speci
c
inde
among
enterovirus
confer
evolutionari
advantag
remain
unclear
observ
like
multipl
occurr
speci
c
absenc
speci
rhinovirus
group
c
sequenc
suggest
possess
group
may
advantag
howev
evid
gain
studi
distinct
epidemiolog
featur
clinic
present
might
origin
hypothesis
fit
differ
hrvca
hrvcc
group
comprehens
screen
hrvc
whole
calendar
year
enabl
season
infect
target
group
clinic
associ
hrvc
infect
compar
respiratori
virus
larg
number
hrvc
infect
episod
detect
period
allow
number
rel
robust
conclus
drawn
firstli
studi
identifi
young
children
infant
main
target
group
hrvc
infect
among
predominantli
hospitalis
individu
age
profil
compar
rsv
virus
infect
observ
less
year
age
fig
higher
adv
influenza
viru
respiratori
virus
target
young
children
compar
observ
hrv
speci
previou
investig
three
hrv
speci
hrvc
similarli
resembl
rhinoviru
speci
season
distribut
fig
circul
throughout
year
report
rhinovirus
howev
show
typic
higher
incid
autumn
found
rhinovirus
human
enterovirus
actual
show
higher
infect
frequenc
winter
month
howev
longer
studi
period
would
requir
discount
effect
yearonyear
fluctuat
incid
speci
c
increasingli
recognis
hrv
collect
underestim
caus
signific
respiratori
ill
frequent
detect
hrvc
monoinfect
substanti
proport
subject
present
lrti
urti
fig
concord
recent
pcrbase
studi
demonstr
numer
signific
role
hrvc
rhinoviru
speci
sever
respiratori
diseas
requir
hospitalis
children
exacerb
asthma
detect
frequenc
hrvc
subject
urti
lrti
significantli
higher
present
without
respiratori
diseas
current
studi
although
approxim
twofold
differ
frequenc
less
observ
categori
rsv
hmpv
parainfluenza
virus
greater
adenovirus
coronavirus
virus
hbovhpev
equal
frequenc
knowledg
publish
inform
rate
asymptomat
infect
speci
c
rhinovirus
hospitalis
patient
gener
commun
howev
total
hrv
detect
frequenc
determin
pcr
produc
highli
variabl
result
review
although
averag
take
latter
averag
estim
assum
speci
c
variant
constitut
quarter
third
hrv
detect
previous
found
subset
current
studi
popul
predict
preval
match
close
control
group
current
studi
increas
frequenc
lrti
urti
group
therefor
consist
propos
aetiolog
role
respiratori
diseas
among
predominantli
hospitalis
studi
subject
current
studi
prospect
collect
inform
diseas
sever
symptom
along
viral
load
inform
studi
subject
control
howev
requir
substanti
find
report
current
studi
sampl
screen
extend
rang
human
respiratori
virus
influenza
b
virus
rsv
adv
hmpv
hbov
hpev
coronavirus
allow
detail
investig
frequenc
viru
coinfect
among
subject
present
respiratori
ill
potenti
interact
posit
neg
strike
observ
evid
interfer
rsv
respiratori
virus
except
adenoviru
hrvc
exampl
detect
frequenc
rsv
among
singleinfect
individu
markedli
reduc
among
coinfect
hrvc
compar
reduct
observ
viru
categori
predominantli
parainfluenza
coronavirus
differ
rsv
show
modest
effect
detect
frequenc
latter
categori
less
twofold
reduct
observ
presenc
rsv
virus
convers
influenc
hrvc
detect
frequenc
consist
hrvc
interf
suscept
infect
rna
virus
rather
opposit
neg
interact
detect
frequenc
viral
load
compar
observ
rna
viru
group
previous
describ
differ
pair
respiratori
virus
report
signific
interf
effect
hrv
speci
rsv
rang
rna
virus
contrast
latter
studi
addit
found
posit
interact
significantli
higher
detect
frequenc
rsv
rna
virus
advposit
sampl
interpret
mechan
underli
observ
viru
interfer
complex
one
unknown
factor
previou
studi
may
significantli
contribut
outcom
virusviru
interact
order
acquisit
infect
exampl
hypothesis
strong
interferon
ifn
respons
respiratori
tract
induc
hrv
infect
may
creat
environ
hostil
infect
virus
rsv
even
though
rsv
express
prevent
ifn
induct
infect
cell
countermeasur
may
larg
ineffect
respiratori
tract
alreadi
induc
antivir
state
prior
infect
hrvc
howev
rsv
infect
respiratori
tract
first
would
effect
subsequ
suscept
individu
hrv
rapid
highli
cytopath
replic
cycl
rhinovirus
enterovirus
seem
design
infect
escap
cell
ifnmedi
respons
becom
effect
may
inde
gener
interf
effect
sensit
rna
dna
virus
infect
respiratori
tract
like
rsv
success
colonis
respiratori
tract
coronavirus
influenza
parainfluenza
virus
depend
wide
varieti
evolv
mechan
evad
intracellular
defenc
ineffect
presensitis
cell
induc
ifn
antivir
state
effect
order
infect
acquir
may
addit
influenc
outcom
coinfect
adenovirus
adv
express
plethora
evas
molecul
substanti
influenc
intracellular
environ
cell
infect
also
broader
paracrin
effect
cytokin
product
respiratori
tract
induct
local
immun
frequent
long
term
persist
adv
infect
suggest
permiss
environ
infect
replic
virus
may
exist
respiratori
tract
advinfect
individu
underli
increas
detect
frequenc
hrvc
rsv
respiratori
virus
coinfect
subject
fig
summari
studi
provid
evid
substanti
clinic
impact
hrv
speci
c
infect
young
children
associ
respiratori
diseas
interf
effect
suscept
viru
infect
futur
studi
illumin
extent
observ
specif
speci
c
share
rhinovirus
recent
surg
interest
rhinovirus
follow
unexpect
discoveri
speci
c
undoubtedli
contribut
major
reapprais
role
three
speci
paediatr
respiratori
diseas
sampl
compris
predominantli
nasopharyng
tracheal
aspir
swab
n
throat
swab
n
bronchoalveolar
lavag
n
routin
screen
follow
respiratori
virus
pcr
adenoviru
adv
influenza
b
parainfluenza
viru
type
respiratori
syncyti
viru
rsv
use
previous
describ
assay
sampl
test
human
bocaviru
hbov
human
parechoviru
hpev
human
metapneumoviru
hmpv
coronavirus
gaunt
et
al
manuscript
prepar
test
sampl
refer
hospit
inpati
accid
emerg
depart
lower
respiratori
tract
infect
lrti
identifi
subject
present
follow
symptom
diagnos
bronchiol
chest
infect
pneumonia
respiratori
failur
short
breath
apnoea
wheez
upper
respiratori
tract
infect
urti
coryza
sore
throat
tonsil
tracheiti
cough
also
classifi
urti
symptom
although
acknowledg
addit
potenti
associ
lower
respiratori
tract
diseas
lead
potenti
misclassif
diseas
categori
absenc
respiratori
symptom
subject
relev
respiratori
symptom
includ
referr
categori
vomit
diarrhoea
trauma
elect
cardiac
surgeri
ethic
approv
anonymis
archiv
screen
diagnost
specimen
obtain
lothian
region
ethic
committe
inform
retain
anonymis
includ
age
band
partial
postcod
record
symptom
clinic
inform
referr
sourc
month
sampl
collect
result
virolog
test
sampl
rna
extract
clinic
specimen
previous
describ
revers
transcript
rna
extract
individu
sampl
pool
ten
random
hexam
use
rt
system
promega
unit
kingdom
describ
previous
amplif
hrvc
region
use
previous
describ
primer
reaction
condit
reposit
antisens
inner
primer
ata
gtr
att
tgi
ttd
agc
cta
tcd
gav
base
posit
number
elsewher
accord
hrv
speci
b
refer
sequenc
select
amplif
hrvc
see
result
underlin
base
design
mismatch
speci
b
sequenc
conserv
within
speci
c
posit
sampl
subsequ
amplifi
four
origin
gene
primer
amplicon
directli
sequenc
sequenc
gener
studi
edit
align
publish
sequenc
use
simmon
sequenc
editor
http
wwwvirusevolutionorg
publish
sequenc
includ
complet
genom
sequenc
hrvc
avail
genbank
speci
c
gene
sequenc
avail
genbank
august
hrvc
type
put
assign
phylogenet
analysi
uncorrect
pairwis
distanc
measur
use
previous
propos
diverg
threshold
phylogenet
tree
construct
neighbour
join
sampl
maximumcompositelikelihood
mcl
distanc
use
mega
softwar
packag
pairwis
delet
miss
data
sequenc
gener
studi
assign
genbank
access
number
hrvc
posit
sampl
identifi
gene
screen
amplifi
region
group
assign
use
heminest
pcr
primer
hca
agi
act
tct
gti
wcc
cc
g
use
first
second
round
antisens
primer
gaa
aca
cgg
aca
ccc
aaa
gta
gt
outer
tta
gcc
rca
ttc
agg
ggc
cgg
inner
use
previous
describ
reaction
condit
small
number
sampl
unamplifi
method
superscript
iii
invitrogen
use
revers
transcript
first
round
pcr
hrvc
variant
assign
speci
c
group
comparison
refer
sequenc
known
group
posit
statist
test
conduct
use
chi
squar
test
yate
correct
confid
interv
unless
state
